Quantcast

Latest Clinical trial Stories

2014-08-12 23:09:28

In support of the Alliance for Clinical Research Excellence and Safety (ACRES) global collaborative model, industry stakeholders have pledged more than $102M in technologies and services to transform the clinical research enterprise and accelerate medicines development, enhancing quality, safety and long-term industry sustainability. (PRWEB) August 12, 2014 Following the recent meeting of a multi-sector global stakeholder consultation on clinical research site-excellence, strategic allies...

2014-08-12 08:31:39

CLEVELAND, Aug. 12, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics, Inc., a private clinical-stage company developing a drug-based approach to regenerative medicine today announced that it successfully completed the Phase I arm of the RETRO-HF clinical trial, and fully enrolled the Phase II arm that is evaluating the safety and preliminary clinical efficacy for retrograde infusion of JVS-100 in patients with heart failure....

2014-08-12 08:29:26

Array planning for potential return of MEK inhibitor BOULDER, Colo., Aug. 12, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the fourth quarter and full year of its fiscal year ending June 30, 2014. http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO Ron Squarer, Chief Executive Officer of Array, noted, "The Array-invented MEK inhibitors, binimetinib and selumetinib, are currently enrolling six Phase 3 trials, and each of our partners has...

2014-08-11 23:06:16

DZS Software Solutions uses results of client feedback to build on a reliable and robust system with ClinPlus® CTMS 2.2. Bound Brook, NJ (PRWEB) August 11, 2014 DZS Software Solutions (DZS), a provider of the ClinPlus® software products and services supporting several aspects of clinical trials, today announced the official release of ClinPlus® CTMS 2.2. This release builds on a reliable and robust system that has gained enormous popularity primarily for its combination...

2014-08-11 23:04:30

New partnership will give better clinical trial access and information to over 100,000 patient influencers. Boston and London (PRWEB) August 11, 2014 TrialReach, the world’s largest provider of clinical research information and patient-clinical trial matching, today announced a new collaboration with WEGO Health, a social network comprised of over 100,000 patient influencers. WEGO Health will expand its TrialShare platform by incorporating TrialReach tools and resources directly so that...

2014-08-11 16:25:35

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Spasticity Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2280943/Spasticity-Global-Clinical-Trials-Review-H2-2014.htmlSpasticity Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Spasticity Global Clinical Trials Review, H2, 2014" provides data on the Spasticity clinical trial scenario. This report provides elemental information and...

2014-08-11 16:25:30

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2280941/Spastic-Cerebral-Palsy-Global-Clinical-Trials-Review-H2-2014.htmlSpastic Cerebral Palsy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2014" provides data on the Spastic Cerebral Palsy clinical...

2014-08-11 16:25:21

LONDON, Aug. 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Renal Pain Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/703965/Renal-Pain-Global-Clinical-Trials-Review-H2-2014.htmlRenal Pain Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Renal Pain Global Clinical Trials Review, H2, 2014" provides data on the Renal Pain clinical trial scenario. This report provides elemental information and...

2014-08-11 08:29:18

Trial Progressing On Track; BETHESDA, Md., Aug. 11, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced an update about the Company's Phase III clinical trial of DCVax®-L for Glioblastoma multiforme (GBM) brain cancer in conjunction with the Company's separate announcement today about certain changes to the Phase III trial. The update from the Company...

2014-08-11 08:28:51

With CE mark in place and FDA-directed studies underway in US, company accelerates market development efforts in US, Canada, Israel, and multiple countries in Europe ENGLEWOOD, Colo., Aug. 11, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that subsidiary Luoxis Diagnostics has expanded its academic and pharmaceutical research network to over 25 sites around the world. To date the company has initiated over 17 scientific and clinical research...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related